Clinical outcomes and hospital-reported cost associated with surgical site infections and the co-occurrence of hospital-onset bacteremia and fungemia across US hospitals
Infection Control & Hospital Epidemiology · 2025-04 · 46 (4) · 391-397
DOI: 10.1017/ice.2025.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 19.02.2025. Verfasst von ChinEn Ai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Affairs, Becton Dickinson and Company, Franklin Lakes, NJ, USA. Hauptthemen laut MEDLINE: Surgical Wound Infection, Bacteremia, Cross Infection, Fungemia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the hospital-reported cost of care, clinical burden, and incidence of hospital-onset bacteremia and fungemia (HOB) for hospital admissions with surgical site infections (SSI).
Methods
A cross-sectional study of 38 acute-care hospital admissions with a procedure under the National Healthcare Safety Network (NHSN) surveillance for SSI was conducted. SSI admissions were identified through NHSN reporting by the hospital. Clinical outcomes were estimated for SSI compared to no SSI controls using propensity matching and multivariable adjusted models that controlled for patient and hospital demographics; these endpoints were also compared for SSI admissions with and without HOB co-occurrence.
Results
The rate of hospital-reported SSI was 0.15 per 100 admissions with a procedure under surveillance for SSI. Admissions with SSI compared to no SSI had significantly higher incremental hospital-reported cost of $30,689 and length of stay (LOS) was 11.6 days higher. The incidence of HOB was 6-fold higher in admissions with SSI compared to no SSI. For SSI admissions with HOB vs. no HOB, HOB added $28,049 to cost of care and 6.5 days to the LOS.
Conclusions
Hospital-reported SSIs were associated with higher clinical and economic burden. Patients with SSI and HOB had even more deleterious outcomes. These data may inform programs to augment infection prevention bundles targeting SSIs and downstream complications or comorbidities like HOB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Affairs, Becton Dickinson and Company, Franklin Lakes, NJ, USA.
ORCID-Profile: Molly Jung, Samantha Bastow, Kalvin C Yu
Zitieren
APA
Ai, C., Jung, M., Bastow, S., Adjaoute, G., Bostick, D., & Yu, K. C. (2025). Clinical outcomes and hospital-reported cost associated with surgical site infections and the co-occurrence of hospital-onset bacteremia and fungemia across US hospitals. Infection Control & Hospital Epidemiology, 46(4), 391-397. https://doi.org/10.1017/ice.2025.13
Vancouver
Ai C, Jung M, Bastow S, Adjaoute G, Bostick D, Yu KC. Clinical outcomes and hospital-reported cost associated with surgical site infections and the co-occurrence of hospital-onset bacteremia and fungemia across US hospitals. Infection Control & Hospital Epidemiology. 2025;46(4):391-397. doi:10.1017/ice.2025.13
BibTeX
@article{Ai2025,
author = {Ai, ChinEn and Jung, Molly and Bastow, Samantha and Adjaoute, Ghislene and Bostick, David and Yu, Kalvin C},
title = {Clinical outcomes and hospital-reported cost associated with surgical site infections and the co-occurrence of hospital-onset bacteremia and fungemia across US hospitals},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
volume = {46},
number = {4},
pages = {391--397},
doi = {10.1017/ice.2025.13}
}
EUVIMED